MED10 and bladder transitional cell carcinoma: To rule out multifactorial inter-sample inconsistencies/variation and establish replicability of the observed expression profile, our gene detectability power analysis of the GSE81157 aggressive BLCA cohort (n = 9) showed that variation in the true abundance of MED10 (biological coefficient of variation, BCOV = 0.17, power = 0.99) or hsa-miR-590 (BCOV = 0.45, power = 0.02) between replicate RNA samples was apparently insignificant (Figure 5C).